Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


YOUR CHOICE


Clinically superior solutions that last a lifetime

LATEST NEWS


Admedus announces Non-Executive Director resignation and appointment
Admedus Limited (ASX:AHZ) (“the Company”) announces that Dr Simon Buckingham has resigned as Non-Executive Director of Admedus Limited, effective 4
Read more.
Admedus welcomes new opportunities in Emerging Markets
Admedus Limited (ASX:AHZ), is pleased to announce recent developments in the Emerging Markets with the introduction of CardioCel® to Vietnam
Read more.